NYSE:WATWaters Stock Price, Forecast & News

Waters' stock was trading at $184.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, WAT shares have increased by 6.4% and is now trading at $195.93. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View analyst ratings for Waters.

Waters is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for Waters.

Waters Co. (NYSE:WAT) released its earnings results on Tuesday, February, 4th. The medical instruments supplier reported $3.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.01 by $0.19. The medical instruments supplier earned $716 million during the quarter, compared to the consensus estimate of $714.34 million. Waters had a net margin of 24.61% and a return on equity of 172.16%. The firm's quarterly revenue was up .1% on a year-over-year basis. During the same period last year, the business earned $2.87 EPS. View Waters' earnings history.

Waters announced that its board has initiated a share buyback program on Tuesday, April 24th 2018, which authorizes the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to buy up to 18.2% of its stock through open market purchases. Stock buyback programs are often an indication that the company's board believes its shares are undervalued.

Waters issued an update on its FY20 earnings guidance on Tuesday, February, 4th. The company provided earnings per share guidance of $9.15-$9.40 for the period, compared to the Thomson Reuters consensus estimate of $9.80.

11 Wall Street analysts have issued 1-year target prices for Waters' stock. Their forecasts range from $150.00 to $230.00. On average, they anticipate Waters' stock price to reach $184.86 in the next year. This suggests that the stock has a possible downside of 5.7%. View analysts' price targets for Waters.

News coverage about WAT stock has been trending very negative this week, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Waters earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutWaters.

Waters saw a decrease in short interest in March. As of March 13th, there was short interest totaling 4,335,600 shares, a decrease of 7.8% from the February 27th total of 4,700,000 shares. Based on an average daily volume of 514,100 shares, the short-interest ratio is presently 8.4 days. Currently, 7.0% of the company's stock are sold short. View Waters' Current Options Chain.

Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Bruker (BRKR), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Honeywell International (HON), Alibaba Group (BABA), Home Depot (HD), CVS Health (CVS), Verizon Communications (VZ), Cisco Systems (CSCO), Raytheon (RTN), Procter & Gamble (PG) and AT&T (T).

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters' stock is owned by many different institutional and retail investors. Top institutional investors include Mountain Pacific Investment Advisers Inc. ID (0.12%), Independent Investors Inc. (0.08%), Investment House LLC (0.04%), State of Alaska Department of Revenue (0.03%), IFM Investors Pty Ltd (0.01%) and Bank of Stockton (0.01%). Company insiders that own Waters stock include Christopher A Kuebler, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View institutional ownership trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Mountain Pacific Investment Advisers Inc. ID, Investment House LLC, IFM Investors Pty Ltd, Independent Investors Inc., Contravisory Investment Management Inc., Ipswich Investment Management Co. Inc., Bank of Stockton, and Mitchell Mcleod Pugh & Williams Inc.. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, and Mark T Beaudouin. View insider buying and selling activity for Waters.

WAT stock was acquired by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, IBM Retirement Fund, and Fulton Bank N.A.. View insider buying and selling activity for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $195.93.

Waters has a market capitalization of $12.18 billion and generates $2.41 billion in revenue each year. The medical instruments supplier earns $592.20 million in net income (profit) each year or $8.99 on an earnings per share basis. Waters employs 7,500 workers across the globe. View additional information about Waters.

The official website for Waters is http://www.waters.com/.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]